AthenaHealth beats by $0.04, beats on revs; guides FY11 EPS in-line, revs in-line (63.07 +1.89) : Reports Q3 (Sep) earnings of $0.24 per share, excluding non-recurring items, $0.04 better than the Capital IQ Consensus Estimate of $0.20; revenues rose 32.6% year/year to $83.7 mln vs the $82.6 mln consensus. Co issues in-line guidance for FY11, sees EPS of $0.78-0.85, excluding non-recurring items, vs. $0.83 Capital IQ Consensus Estimate; sees FY11 revs of $320-325 mln vs. $321.5 mln Capital IQ Consensus Estimate. Non-GAAP adjusted gross margin was 63.8%, up from 62.8% a year ago. "The growth we achieved during Q3 reflects strong market demand for our services
The company earning report issued yesterday after hours was passable - selling intensified as day progressed. Support lies around $50. The stock closed down about 7% for the day.
The market had a good bull day.
AthenaHealth 3Q11 follow-up: eyes turn to 2012 - Oppenheimer (58.70 )
Oppenheimer notes while 3Q was essentially in line with its ests, firm is raising its 2012E rev to incorporate higher than expected doc adds in the quarter, as well as the announcement of the expansion with Vanguard for the Detroit Medical Center. However, the lack of a new enterprise win combined with the dependence on its customer base being acquisitive concerns firm as it estimates new doc adds for next year relative to expectations. While physician adds have been strong the past two quarters, without a pick-up in enterprise wins, firm believes ATHN's robust growth could stall by 2H11
PRGO IS A NEW SELL
Perrigo beats by $0.04, misses on revs; guides FY12 EPS above consensus (98.83 ) : Reports Q1 (Sep) earnings of $1.10 per share, excluding non-recurring items, $0.04 better than the Capital IQ Consensus Estimate of $1.06; revenues rose 13.1% year/year to $725.3 mln vs the $751.1 mln consensus. Co issues upside guidance for FY12, sees EPS of $4.65-4.80, excluding non-recurring items, vs. $4.63 Capital IQ Consensus Estimate and vs. prior guidance of $4.50-4.65.
I WILL SHORT IT ON ANY ATTEMPT TO RALLY
Want to comment on this post? Sign up now.It's FREE!
Already registered? Log In.
Sponsored Links
Zacks Top Ten Stocks for 2011 are now available! This 10-stock portfolio is a well-balanced mix of aggressive and conservative, large and small cap, growth and value. Buy them. Hold them. Watch your gains add up
Ride Momentum Stocks to Quick Gains!
The market is finally breaking out, creating the perfectd wave for investing in momentum stocks. Zacks is the king of fundamental analysis, but this service also uses technical indicators for the best possible timing. Click here to learn more >>.
Stock screening and chart patterns expert, Kevin Matras, combs through the best Zacks stock-picking strategies averaging +60% yearly gains to find stocks with charts showing they are ready to skyrocket. Chart Patterns Trader >>